or Try an Advanced Search...

    Technical Analysis for IPSC - Century Therapeutics, Inc.

    Grade Last Price % Change Price Change
    D 3.07 -8.90% -0.30
    IPSC closed down 8.9 percent on Wednesday, May 8, 2024, on 65 percent of normal volume.
    Earnings due: May 13
    *** please verify all earnings dates ***
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Flat
    Historical IPSC trend table...
    Date Alert Name Type % Chg
    Fell Below 20 DMA Bearish 0.00%
    Wide Bands Range Expansion 0.00%
    Crossed Above 20 DMA Bullish -8.90%
    Wide Bands Range Expansion -8.90%
    Up 3 Days in a Row Strength -8.90%
    20 DMA Resistance Bearish -3.15%
    Wide Bands Range Expansion -3.15%
    Pocket Pivot Bullish Swing Setup 1.32%
    Wide Bands Range Expansion 1.32%
    Gapped Up Strength 1.32%
    Older End-of-Day Signals for IPSC ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Support about 16 hours ago
    Down 10% about 16 hours ago
    20 DMA Support about 21 hours ago
    Fell Below Previous Day's Low about 21 hours ago
    60 Minute Opening Range Breakdown about 21 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    IPSC Chart by TradingView
    Basic chart:

    Profile

    Century Therapeutics is harnessing the power of adult stem cells to develop curative cell therapy products for cancer that we believe will allow us to overcome the limitations of first-generation cell therapies. Our genetically engineered, iPSC-derived iNK and iT cell products are designed to specifically target hematologic and solid tumor cancers. We believe our commitment to developing off-the-shelf cell therapies will expand patient access and provides an opportunity to advance the course of cancer care.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Cancer Life Sciences Biology Stem Cell Cell Therapy Cell Biology Cancer Care Induced Stem Cells Cloning

    Is IPSC a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 23 Century Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
    Apr 11 Century buys a startup, raises funding in cell therapy expansion
    Apr 11 Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics
    Apr 8 Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual Meeting
    Mar 29 Century Therapeutics (NASDAQ:IPSC) Will Have To Spend Its Cash Wisely
    Mar 25 Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors
    Mar 20 Amneal (AMRX) Stock Jumps 7.3%: Will It Continue to Soar?
    Mar 19 Century Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
    Mar 14 Century Therapeutics GAAP EPS of -$2.30, revenue of $2.2M
    Mar 14 Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updates
    See more IPSC news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.51
    52 Week Low 1.28
    Average Volume 132,867
    200-Day Moving Average 2.95
    50-Day Moving Average 3.87
    20-Day Moving Average 3.17
    10-Day Moving Average 3.07
    Average True Range 0.38
    RSI (14) 43.82
    ADX 13.26
    +DI 24.35
    -DI 15.19
    Chandelier Exit (Long, 3 ATRs) 3.29
    Chandelier Exit (Short, 3 ATRs) 3.89
    Upper Bollinger Bands 3.82
    Lower Bollinger Band 2.53
    Percent B (%b) 0.42
    BandWidth 40.52
    MACD Line -0.20
    MACD Signal Line -0.26
    MACD Histogram 0.0564
    Fundamentals Value
    Market Cap 183.69 Million
    Num Shares 59.8 Million
    EPS -2.20
    Price-to-Earnings (P/E) Ratio -1.40
    Price-to-Sales 103.41
    Price-to-Book 1.21
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.60
    Resistance 3 (R3) 3.63 3.50 3.51
    Resistance 2 (R2) 3.50 3.36 3.48 3.48
    Resistance 1 (R1) 3.28 3.28 3.22 3.25 3.45
    Pivot Point 3.15 3.15 3.11 3.13 3.15
    Support 1 (S1) 2.93 3.01 2.87 2.90 2.69
    Support 2 (S2) 2.80 2.93 2.78 2.66
    Support 3 (S3) 2.58 2.80 2.63
    Support 4 (S4) 2.55